Skip to main content
. 2021 Aug 26;60:45–52. doi: 10.1016/j.breast.2021.08.015

Table 2.

BRRM uptake at 10 and 20 years by risk group and additional factors.



BRRM
Competing risks (breast cancer/death)
10 year % (95%CI) 20 year % (95%CI) 10 year % (95%CI) 20 year % (95%CI)
Risk group 25–29% 2.39 (1.69–3.38) 2.92 (2.09–4.09) 4.33 (3.31–5.65) 7.92 (6.37–9.84)
30–39% 3.66 (3.03–4.41) 4.78 (3.98–5.73) 4.58 (3.85–5.44) 8.73 (7.48–10.18)
40–49% 7.39 (5.96–9.14) 9.04 (7.26–11.24) 5.13 (3.95–6.67) 11.25 (9.05–13.96)
BRCA1/2 45.00 (40.18–50.11) 47.67 (42.40–53.24) 9.11 (6.55–12.59) 14.05 (10.08–19.41)
Mother BC No FDR died BC 5.67 (5.05–6.37) 6.73 (5.98–7.58) 4.55 (3.96–5.22) 8.72 (7.70–9.88)
Mother BC death 10.22 (8.52–12.25) 11.68 (9.78–13.93) 5.53 (4.27–7.16) 10.72 (8.71–13.17)
Sister BC Sister death 10.49 (7.60–14.38) 11.66 (8.57–15.77) 6.06 (3.90–9.35) 11.19 (1.93–15.64)
Age entry <30 8.77 (6.89–11.13) 11.93 (9.44–15.03) 1.50 (0.90–2.80) 5.05 (3.29–7.71)
30–39 8.46 (7.46–9.59) 9.42 (8.32–10.67) 3.93 (3.22–4.78) 8.36 (7.05–9.89)
40–49 4.41 (3.59–5.41) 5.33 (4.34–6.54) 5.67 (4.70–6.83) 10.07 (8.53–11.87)
50+ 3.79 (2.64–5.43) 3.79 (2.64–5.43) 8.88 (6.91–11.39) 13.78 (10.95–17.28)
Biopsy No 6.34 (5.73–7.02) 7.40 (6.69–8.19) 5.22 (4.64–5.88) 9.93 (8.95–11.02)
Yes 9.24 (7.05–12.07) 10.88 (8.37–14.09) 0.40 (0.10–1.61) 2.09 (0.10–4.43)
Parity Nulliparous 5.21 (4.20–6.45) 7.34 (6.60–8.16) 4.48 (3.51–5.70) 7.42 (5.93–9.27)
Parous 6.32 (5.07–7.87) 8.49 (7.64–9.42) 4.97 (4.35–5.69) 9.82 (8.75–11.01)
Era <1994 4.50 (3.04–6.65) 5.79 (4.08–8.18) 6.23 (4.47–8.66) 15.96 (12.98–19.55)
1994–2003 5.89 (5.00–6.92) 6.97 (5.98–8.11) 5.57 (4.71–6.59) 9.39 (8.22–10.73)
2003-04/2013 7.86 (6.82–9.04) 9.13 (7.77–10.79) 4.48 (3.69–5.43) 5.46 (4.47–6.67)
≥ May 2013 14.17 (4.82–37.7) 14.17 (4.82–37.7) 0.87 (0.05–1.57) 0.87 (0.05–1.57)

RRM – Risk reducing mastectomy, BC – breast cancer, FDR – first degree relative.